Is Samsung's Smartphone Surge in Jeopardy?

June 7 (Bloomberg) -- Samsung fell the most in more than nine months in Seoul after analysts at JPMorgan cut profit estimates, citing slowing demand for its flagship Galaxy S4. Logitech CEO Bracken Darrell speaks with Cory Johnson on Bloomberg Television's "Bloomberg West. (Source: Bloomberg)

Merck KgaA, Pfizer Cancer Drug to Cost $13,000 a Month
11:04 - Pfizer and Merck KGaA’s cancer immunotherapy won approval from U.S. regulators for patients with a rare form of skin cancer, and the companies plan to sell the drug for $13,000 a month. Merck KgaA CEO Stegfan Oschmann speaks on "Bloomberg Daybreak Europe." (Source: Bloomberg)
  • Aviva's Diebel Sees No Macro Impact From Healthcare Bill
  • Italy Junior Minister Sees Brexit as EU Opportunity
  • French Presidential Race Takes an Inflammatory Turn